PIRS

Pieris Pharmaceuticals, Inc. PIRS

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PIRS CSCI NYMXF ATON TRAW MEIP KA MTVA PHXM ELEV
6M 98.54 % 0.00 % 16.48 % -55.44 % 84.14 % 63.30 % 18.21 % 28.75 % -33.05 % -39.91 %
YTD 0.00 % -0.37 % 6.00 % 8.20 % -69.20 % 20.39 % -83.10 % -53.56 % -35.42 % -38.67 %
1Y -4.96 % -26.49 % -29.33 % -4.86 % -46.28 % 13.70 % -83.49 % -61.27 % -62.92 % -54.38 %
3Y -95.03 % -54.67 % -71.35 % -95.98 % -85.17 % -59.61 % -98.76 % -61.27 % -95.51 % -70.80 %
5Y -94.89 % -54.67 % -94.48 % -97.22 % -97.26 % -95.06 % -99.28 % -61.27 % -95.88 % -96.81 %
10Y -93.82 % -54.67 % -96.82 % -98.11 % -100.00 % -90.92 % -99.92 % -61.27 % -98.73 % -96.81 %
From the beginning -93.82 % -54.67 % -98.37 % -97.60 % -100.00 % -99.97 % -99.92 % -61.27 % -98.73 % -96.81 %

Dividend

MEI Pharma, Inc.

Kineta, Inc.